MXPA02011922A - Sistema terapeutico transdermico oclusivo con una capa de respaldo no oclusiva. - Google Patents

Sistema terapeutico transdermico oclusivo con una capa de respaldo no oclusiva.

Info

Publication number
MXPA02011922A
MXPA02011922A MXPA02011922A MXPA02011922A MXPA02011922A MX PA02011922 A MXPA02011922 A MX PA02011922A MX PA02011922 A MXPA02011922 A MX PA02011922A MX PA02011922 A MXPA02011922 A MX PA02011922A MX PA02011922 A MXPA02011922 A MX PA02011922A
Authority
MX
Mexico
Prior art keywords
occlusive
backing layer
therapeutic system
backing layers
transdermal therapeutic
Prior art date
Application number
MXPA02011922A
Other languages
English (en)
Inventor
Stefan Bracht
Original Assignee
Lohmann Therapie Syst Lts
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lohmann Therapie Syst Lts filed Critical Lohmann Therapie Syst Lts
Publication of MXPA02011922A publication Critical patent/MXPA02011922A/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
    • A61K9/703—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
    • A61K9/7038—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer
    • A61K9/7046—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds
    • A61K9/7053—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds obtained by reactions only involving carbon to carbon unsaturated bonds, e.g. polyvinyl, polyisobutylene, polystyrene
    • A61K9/7061—Polyacrylates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10T—TECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION
    • Y10T442/00—Fabric [woven, knitted, or nonwoven textile or cloth, etc.]
    • Y10T442/20—Coated or impregnated woven, knit, or nonwoven fabric which is not [a] associated with another preformed layer or fiber layer or, [b] with respect to woven and knit, characterized, respectively, by a particular or differential weave or knit, wherein the coating or impregnation is neither a foamed material nor a free metal or alloy layer
    • Y10T442/2525—Coating or impregnation functions biologically [e.g., insect repellent, antiseptic, insecticide, bactericide, etc.]

Landscapes

  • Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Dermatology (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Rheumatology (AREA)
  • Pain & Pain Management (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)

Abstract

El sistema inventivo comprende sustancialmente una capa adhesiva de dos fases que contiene una sustancia activa; una fase interior (2) que contiene la sustancia activa en forma disuelta que esta integrada en la fase exterior impermeable al vapor (3) en una forma dispersada; combinada con una capa de respaldo elastica (1), de preferencia una tela elastica de urdimbre/trama, se obtiene un sistema matriz muy delgado que garantiza una excelente comodidad en el uso y que utiliza en forma optima el efecto oclusivo para una absorcion mejorada de la sustancia activa por la piel.
MXPA02011922A 2000-05-31 2001-05-15 Sistema terapeutico transdermico oclusivo con una capa de respaldo no oclusiva. MXPA02011922A (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE10027258A DE10027258C1 (de) 2000-05-31 2000-05-31 Transdermales therapeutisches System mit okklusiver wirkstoffhaltiger Schicht und nicht-okklusiver Rückschicht
PCT/EP2001/005474 WO2001091718A2 (de) 2000-05-31 2001-05-15 Okklusives transdermales therapeutisches system mit nicht-okklusiver rückschicht

Publications (1)

Publication Number Publication Date
MXPA02011922A true MXPA02011922A (es) 2003-04-22

Family

ID=7644389

Family Applications (1)

Application Number Title Priority Date Filing Date
MXPA02011922A MXPA02011922A (es) 2000-05-31 2001-05-15 Sistema terapeutico transdermico oclusivo con una capa de respaldo no oclusiva.

Country Status (13)

Country Link
US (1) US8323684B2 (es)
EP (1) EP1284718B1 (es)
JP (1) JP4428903B2 (es)
KR (1) KR100767900B1 (es)
AT (1) ATE321540T1 (es)
AU (2) AU1013202A (es)
CA (1) CA2407854C (es)
DE (2) DE10027258C1 (es)
DK (1) DK1284718T3 (es)
ES (1) ES2260302T3 (es)
MX (1) MXPA02011922A (es)
PT (1) PT1284718E (es)
WO (1) WO2001091718A2 (es)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7063859B1 (en) 1999-04-28 2006-06-20 Noven Pharmaceuticals, Inc. Barrier film lined backing layer composition and method for topical administration of active agents
DE10118282A1 (de) * 2001-04-12 2002-12-05 Lohmann Therapie Syst Lts Haftkleber auf Basis von Ethylen-Vinylacetat-Copolymeren und Klebharzen, für medizinische Verwendungszwecke
DE10159745A1 (de) * 2001-12-05 2003-07-03 Lohmann Therapie Syst Lts Transdermales Therapeutisches System mit verbessertem Langzeittragekomfort
US20050137262A1 (en) * 2003-12-22 2005-06-23 Hu Patrick C. Highly concentrated pourable aqueous solutions of potassium ibuprofen, their preparation and their uses
DE102007006244B4 (de) 2007-02-08 2012-03-15 Lts Lohmann Therapie-Systeme Ag Transdermales Therapeutisches System zur Verabreichung wasserlöslicher Wirkstoffe
FR2924349B1 (fr) 2007-12-03 2010-01-01 Dbv Tech Methode de desensibilitation aux allergenes
EP2366388A1 (de) 2010-03-17 2011-09-21 Ratiopharm GmbH Nicht-okklusives transdermales therapeutisches System zur Verabreichung von Buprenorphin
DE102011114411A1 (de) * 2011-09-26 2013-03-28 Lts Lohmann Therapie-Systeme Ag Pflaster mit einstellbarer Okklusion
WO2014159798A1 (en) 2013-03-13 2014-10-02 Avery Dennison Corporation Improving adhesive properties
EP2921184A1 (de) * 2014-03-19 2015-09-23 LTS LOHMANN Therapie-Systeme AG Überpflaster mit verbesserter Verträglichkeit und einer langen Haftungsdauer und Verfahren zu seiner Herstellung
ES2942327T3 (es) * 2015-05-21 2023-05-31 Adhexpharma Sas Apósito con capa de soporte bielástica
EP3384904A1 (en) 2017-04-03 2018-10-10 tesa Labtec GmbH Pharmaceutical preparation for dermal administration

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2542998B1 (fr) 1983-03-24 1986-01-31 Rhone Poulenc Sante Nouvelle forme transdermale du dinitrate d'isosorbide
DE3347278A1 (de) 1983-12-28 1985-07-11 Bayer Ag, 5090 Leverkusen Wirkstoffabgabesysteme
DE3409079A1 (de) 1984-03-13 1985-09-19 Bayer Ag, 5090 Leverkusen Medizinische pflaster
DE58906975D1 (de) * 1988-08-02 1994-03-24 Ciba Geigy Mehrschichtiges Pflaster.
DE3910543A1 (de) 1989-04-01 1990-10-11 Lohmann Therapie Syst Lts Transdermales therapeutisches system mit erhoehtem wirkstofffluss und verfahren zu seiner herstellung
US5270358A (en) * 1989-12-28 1993-12-14 Minnesota Mining And Manufacturing Company Composite of a disperesed gel in an adhesive matrix
US5989586A (en) * 1992-10-05 1999-11-23 Cygnus, Inc. Two-phase matrix for sustained release drug delivery device
JPH0912448A (ja) * 1995-04-28 1997-01-14 Read Chem Kk 薬物放出制御型経皮吸収製剤
DE19733981A1 (de) 1997-08-06 1999-02-11 Lohmann Therapie Syst Lts Transdermales Therapeutisches System (TTS) zur Abgabe von Wirkstoff durch die Haut an einen Organismus und Verfahren zur Applikation auf der Haut
DE19918105C1 (de) 1999-04-22 2000-09-21 Lohmann Therapie Syst Lts Transdermales therapeutisches System mit einem stark wirksamen Neuroleptikum
US6582724B2 (en) * 1999-12-16 2003-06-24 Dermatrends, Inc. Dual enhancer composition for topical and transdermal drug delivery

Also Published As

Publication number Publication date
KR100767900B1 (ko) 2007-10-17
EP1284718A2 (de) 2003-02-26
JP2003534365A (ja) 2003-11-18
US8323684B2 (en) 2012-12-04
PT1284718E (pt) 2006-07-31
WO2001091718A3 (de) 2002-05-10
CA2407854A1 (en) 2002-10-29
JP4428903B2 (ja) 2010-03-10
DK1284718T3 (da) 2006-07-24
AU2002210132B2 (en) 2004-11-25
WO2001091718A2 (de) 2001-12-06
DE50109398D1 (de) 2006-05-18
KR20030005435A (ko) 2003-01-17
EP1284718B1 (de) 2006-03-29
US20030133970A1 (en) 2003-07-17
DE10027258C1 (de) 2001-10-31
AU1013202A (en) 2001-12-11
CA2407854C (en) 2009-05-05
ATE321540T1 (de) 2006-04-15
ES2260302T3 (es) 2006-11-01

Similar Documents

Publication Publication Date Title
MXPA02011922A (es) Sistema terapeutico transdermico oclusivo con una capa de respaldo no oclusiva.
PT93191A (pt) Sistema terapeutico para a administracao retardada e controlada transdermica ou transmucosica de substancias activas
ATE288743T1 (de) Pharmazeutische trägervorrichtung welche zur verabreichung von wirkstoffen an schleimhautoberflächen geeignet ist
AU4923500A (en) Device and method for increasing the transdermal permeation of medicaments
DK1014954T3 (da) Transdermalt terapeutisk system
MXPA03010991A (es) Composicion permeable a la piel que comprende inhibidor de ciclooxigenasa-a selectivo y alcohol monohidrico.
DK0729750T3 (da) Kosmetisk, farmaceutisk eller dermatologisk præparat, der indeholder TNF-alfa
PT973497E (pt) Dispositivo transportador farmaceutico adequado para administracao de compostos farmaceuticos a superficies mucosas
AR016798A1 (es) Uso de una cepa de lactobacillus para la elaboracion de un medicamento
FI19991893A (fi) Säädellysti budesonidia vapauttava oraalisesti annettava koostumus ja budesonidin käyttö
TW570815B (en) Transdermal therapeutic system (TTS) containing the active substance fentanyl
MXPA06012960A (es) Administracion transdermal de ficotoxinas.
FI961282A (fi) Transdermaalinen terapeuttinen systeemi, jossa on asetyylisalisyylihappo vaikuttavana aineena
KR950702811A (ko) 프린트 경피약제투여장치(Printed Transdermal Drug Delivery Device)
ES2124983T5 (es) Utilizacion de un antagonista de substancia p para el tratamiento de las manchas rojas cutaneas de origen neurogeno.
NO992674L (no) Konturen til et transdermalt terapeutisk system
ES2063172T3 (es) Sistema terapeutico superficial con una sustancia activa antineoplasica, en especial 5-fluoruracilo.
WO2011066970A3 (de) Transdermales therapeutisches system für die verabreichung von peptiden
WO2008049903A3 (en) Wide-area parasystemic treatment of skin related conditions
DE60135454D1 (de) Pharmazeutische gel-zusammensetzung
HUP0204180A2 (hu) Külsőleges készítmény és alkalmazása allergiás dermatitisz kezelésére
ES2188021T3 (es) Metodo para evitar el uso indebido de un sistema terapeutico percutaneo.
DE59504233D1 (de) Estradiol-tts mit wasserbindenden zusätzen
WO2001041771A3 (de) Acetylsalicylsäure enthaltendes transdermales system zur behandlung von migräne
AR029883A1 (es) Composiciones para la administracion topica que comprende ascomicina y el uso de un vehiculo portador de dicha composicion para la preparacion de un medicamento

Legal Events

Date Code Title Description
FG Grant or registration